ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

INTS Intesity Therapeutics Inc

3.86
-0.14 (-3.50%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Intesity Therapeutics Inc INTS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.14 -3.50% 3.86 16:16:11
Open Price Low Price High Price Close Price Previous Close
3.95 3.85 3.95 3.86 4.00
more quote information »

Recent News

Date Time Source Heading
4/02/202407:01PRNUSIntensity Therapeutics to Participate in the LD Micro..
3/26/202407:01GLOBEPortage Biotech Completes Monetization of Intensity..
3/14/202415:09PRNUSIntensity Therapeutics Reports Full Year 2023 Financial..
3/14/202407:00PRNUSIntensity Therapeutics to Participate in the 36th Annual..
3/07/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202407:01PRNUSIntensity Therapeutics to Present at the 2024 BIO CEO &..
2/07/202415:15EDGAR2Form 8-K - Current report
1/03/202407:01PRNUSIntensity Therapeutics Provides Business Update Reflecting..
12/12/202307:02EDGAR2Form 8-K - Current report
12/12/202307:01PRNUSIntensity Therapeutics Appoints Joseph Talamo, CPA, as Chief..
12/08/202307:30PRNUSIntensity Therapeutics Presents Positive INT230-6 Data in..
12/01/202307:01PRNUSIntensity Therapeutics Selected for Spotlight Oral..
11/13/202311:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202307:02EDGAR2Form 8-K - Current report
11/13/202307:01PRNUSIntensity Therapeutics Reports Third Quarter Financial..
11/02/202306:01PRNUSIntensity Therapeutics Presents Positive INT230-6 Data in..
9/07/202307:01PRNUSIntensity Therapeutics Receives Orphan Drug Designation for..
9/05/202307:01PRNUSIntensity Therapeutics to Present at the H.C. Wainwright..
8/14/202306:01PRNUSIntensity Therapeutics Reports Second Quarter Financial..
8/07/202306:01PRNUSIntensity Therapeutics to Announce Financial Results for the..
7/10/202307:00PRNUSIntensity Therapeutics, Inc. Announces the Closing and Full..
7/05/202315:15PRNUSIntensity Therapeutics, Inc. Announces Closing of Upsized..
6/29/202319:00PRNUSIntensity Therapeutics, Inc. Announces Pricing of Upsized..
6/06/202306:35PRNUSIntensity Therapeutics Reports INT230-6 Can Cause Immune..
6/03/202307:00PRNUSIntensity Therapeutics' INT230-6 Prolongs Survival Alone or..

Your Recent History

Delayed Upgrade Clock